First, the market momentum for Mirum's rare liver disease drug Livmarli should continue. Sales increased 56% year-over-year ...

While artificial intelligence and gold have been all the rage lately, investors looking for the best growth stocks for the ...

A strong performance during a single year may not be indicative of whether a company can perform well over a decade, but ...

Growth and mid-cap stocks often occupy the same corners of the market. They are typically past the fragile early stages that ...

The S&P 500 Dividend Aristocrats tracks companies in the index that have raised dividends every year for at least 25 straight ...

And a whole bunch more are now coming on board. During the third quarter of last year, Upstart's 428,056 loan originations were up 128% year over year, driving revenue up 71% to $277 million and ...

The US stock market could be headed for another growth spurt.

Explore why PepsiCo, Hormel, and Lowe’s look like long-term buys in 2025—attractive valuations, strong dividends, and key ...

The third no-brainer stock that can be confidently bought with $1,000 right now for the new year is America's largest ...

The iShares Core Dividend Growth ETF (NYSEARCA:DGRO) delivers exactly what its name promises: dividend growth, not dividend ...